MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Intuitive Surgical Inc

Chiusa

SettoreSettore sanitario

494.57 -2.54

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

484.44

Massimo

505.57

Metriche Chiave

By Trading Economics

Entrata

123M

688M

Vendite

374M

2.4B

P/E

Media del settore

76.905

63.778

EPS

2.21

Margine di Profitto

28.506

Dipendenti

15,638

EBITDA

116M

810M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+26.58% upside

Dividendi

By Dow Jones

Utili prossimi

22 apr 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-30B

177B

Apertura precedente

497.11

Chiusura precedente

494.57

Notizie sul Sentiment di mercato

By Acuity

18%

82%

35 / 386 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Intuitive Surgical Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

23 gen 2025, 21:41 UTC

Utili

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 gen 2025, 18:37 UTC

Acquisizioni, Fusioni, Takeovers

Intuitive to Establish Direct Presence in Europe With Acquisition

18 ott 2024, 15:22 UTC

Utili
I principali Market Mover

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17 ott 2024, 21:33 UTC

Utili
I principali Market Mover

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17 ott 2024, 20:56 UTC

Utili

Intuitive Surgical Posts 3Q Revenue Growth

24 gen 2025, 21:17 UTC

Utili

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 gen 2025, 18:18 UTC

Utili

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 gen 2025, 13:11 UTC

Notizie principali

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 gen 2025, 09:51 UTC

Azioni calde

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 gen 2025, 21:10 UTC

Utili

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 gen 2025, 21:09 UTC

Utili

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 gen 2025, 21:09 UTC

Utili

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q Net $685.7M >ISRG

23 gen 2025, 21:05 UTC

Utili

Intuitive Surgical 4Q EPS $1.88 >ISRG

15 gen 2025, 17:27 UTC

Utili

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6 gen 2025, 12:00 UTC

Notizie principali

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18 ott 2024, 15:59 UTC

Utili

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18 ott 2024, 15:38 UTC

Utili

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18 ott 2024, 13:28 UTC

Utili

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17 ott 2024, 21:18 UTC

Utili
I principali Market Mover

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

17 ott 2024, 20:22 UTC

Utili

Intuitive Surgical Adds To 41% Run With Massive Profit Beat, Strong Procedure Growth -- IBD

17 ott 2024, 20:05 UTC

Utili

Intuitive Surgical 3Q Adj EPS $1.84 >ISRG

17 ott 2024, 20:05 UTC

Utili

Intuitive Surgical 3Q Rev $2.04B >ISRG

17 ott 2024, 20:05 UTC

Utili

Intuitive Surgical 3Q EPS $1.56 >ISRG

17 ott 2024, 20:05 UTC

Utili

Intuitive Surgical 3Q Net $565.1M >ISRG

19 lug 2024, 13:50 UTC

Principali Notizie su Eventi

Dow Jones, Other Indexes Open Lower As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

19 lug 2024, 13:10 UTC

Principali Notizie su Eventi

Dow Jones Futures Lower, S&P Higher As Global Outage Hits Many Companies; Netflix Climbs After Earnings -- IBD

Confronto tra pari

Modifica del prezzo

Intuitive Surgical Inc Previsione

Obiettivo di Prezzo

By TipRanks

26.58% in crescita

Previsioni per 12 mesi

Media 641.83 USD  26.58%

Alto 711 USD

Basso 570 USD

Basato su 22 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Intuitive Surgical Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

22 ratings

16

Acquista

6

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

492.06 / 508.58Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Weak Bullish Evidence

Sentiment

By Acuity

35 / 386 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.